Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-69.87	10.29	34.16
Graham Fair Price	41.42	2.37	1.68
PEG	-9.56	0.08	-0.09
Price/Book	-2.67	0.80	0.82
Price/Cash Flow	-42.70	13.53	23.61
Prices/Earnings	-51.34	8.09	16.63
Price/Sales	-51.34	0.50	1.03
Price/FCF	-42.70	13.53	23.61
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.24	0.24
Operating Margin	13.62	0.03	0.03
ROA	100.00	0.01	< 0.005
ROE	0.01	0.02	100.00
ROIC	< 0.005	0.02	104.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.10	-0.20	-47.24
Dividends QOQ	1.17	< 0.005	-100.00
EBIT QOQ	2.17	1.27	-41.43
EPS QOQ	1.86	1.00	-46.19
FCF QOQ	-0.64	0.70	9.72
Revenue QOQ	-0.52	1.00	92.13
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	38.54	19.27	-50.00
Days Sales Outstanding (DSO)	60.95	30.53	-49.90
Inventory Turnover	2.34	4.67	100.00
Debt/Capitalization	0.47	0.50	5.19
Quick Ratio	0.85	0.85	0.10
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.18	3.18	< 0.005
Cash	1.68	1.68	< 0.005
Capex	-0.04	-0.07	-100.00
Free Cash Flow	0.11	0.19	69.86
Revenue	2.54	5.09	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.15	1.15	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.38	3.97	-65.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating